/People

Greg Fahy

Founder

Chief Scientific Officer at Intervene Immune

Los Angeles Metropolitan Area

FoundedIntervene Immune

Find your path to Greg

9 people in our graph share verified history with Greg — schools, employers, funds. One of them is your warm intro.

Alain D. BaronunlockedGreg: together at Medical College of Georgia at Augusta University (1974–1977)
×8Greg: together at Medical College of Georgia at Augusta University

About

Greg Fahy is a cryobiologist and biogerontologist serving as Executive Director and Chief Scientific Officer at 21st Century Medicine and co-owner of Intervene Immune. His work in cryobiology centers on organ cryopreservation by vitrification, and in 2009 he published the first report of indefinite life support by a vitrified mammalian organ, a result his lab reproduced with improved outcomes in 2023. In aging research, he published a 2019 clinical trial aimed at reversing immunosenescence that reported signs of epigenetic age reversal, and he authored a chapter on aging as a biologically controlled process in "The Future of Aging: Pathways to Human Life Extension" (Springer, 2010).

Chief Scientific Officer at Intervene Immune

Co-founders at Intervene Immune

RBRobert Brooke
Robert BrookeExecutive Officer, Director

Experience

  1. 21st Century MedicineExecutive Director and CSOcurrent2019 — presentFontana, California
  2. Intervene BiomedicalOwnercurrent1998 — present
  3. Intervene ImmuneChief Scientific Officercurrent2011 — presentLos Angeles Metropolitan Area
  4. Organ, Inc.Chief Scientist1995 — 1997

Skills & more

Lifesciences66BiotechnologyBiochemistry48Molecular Biology57Science39Cell Biology37Cryobiology8Biogerontology4R&D15Biomedical Engineering15Drug Discovery16Microscopy13
+10 moreResearchClinical TrialsAnimal ModelsBioinformaticsClinical ResearchLaboratoryImmunologyPharmacologyCancerGenomics

From Greg's professional profile.

Frequently asked questions

Who is Greg Fahy?
Greg Fahy is a cryobiologist and biogerontologist serving as Executive Director and Chief Scientific Officer at 21st Century Medicine and co-owner of Intervene Immune. His work in cryobiology centers on organ cryopreservation by vitrification, and in 2009 he published the first report of indefinite life support by a vitrified mammalian organ, a result his lab reproduced with improved outcomes in 2023. In aging research, he published a 2019 clinical trial aimed at reversing immunosenescence that reported signs of epigenetic age reversal, and he authored a chapter on aging as a biologically controlled process in "The Future of Aging: Pathways to Human Life Extension" (Springer, 2010).
Where does Greg Fahy work?
Greg Fahy is Chief Scientific Officer of Intervene Immune.
What companies did Greg Fahy found?
Greg Fahy founded Intervene Immune.
Where did Greg Fahy go to school?
Greg Fahy studied at Medical College of Georgia at Augusta University (PhD, Cryobiology and Pharmacology); UC Irvine (B.S., Biology).

Founder mafias

Same school